Califf, experts eye legislative fix for accelerated approval program
Regulatory NewsMary Ellen Schneider
BiologicsBiotechnologyClinical TrialsNorth AmericaPharmaceuticalsProduct LifecycleRegulatory NewsMary Ellen SchneiderBiologicsBiotechnologyClinical TrialsNorth AmericaPharmaceuticalsProduct Lifecycle